Today’s AI Top Pick: IDN
7/17/2026 · Low Float Bullish Consensus Deep Rotation screen · a free sample of K3vl4r’s AI-curated picks.
AI-ranked from a screened shortlist, with entry strategy, targets, and risks.
View the live IDN price forecast →
IDN (Intellicheck) is the cleanest multi-timeframe bullish setup in this pool that isn't already extended. Every single timeframe forecast is positive: 1h +20.5/+23.8/+21.1%, 4h +19.5/+37.6/+49.4%, 1d +15.7/+50.1/+49.5%, 1wk +12.6/+7.1/+2.8%. That is textbook 'all four TFs pointing up' — the gold-standard alignment. Bullish_prob is 1.0 and analyst recom is 1.67 with a 100% targetUpsidePct. Crucially, IDN scores best on the anti-chasing rule: position_in_21bar_range_pct is 0% on 1h, 4h, 1d AND 1wk. Drawdown from the weekly high is -56.5%. RSI is 29.68 — deeply oversold. Contrast this with MORN and HURN, which also have strong fundamentals but are pinned at 100% of range on multiple timeframes with weekly forecasts either flat or negative (HURN weekly fc: -18/-15/-15). MORN's 1h and 4h forecasts are actually negative. Buying MORN/HURN today is chasing a breakout; buying IDN today is buying a washed-out name where the model expects mean-reversion higher. Fundamentals are supportive rather than pristine: PE 34.56 is elevated but fwdPe of 22.06 with epsNextY of 25.93% growth and salesYoY of 15.26% keeps it a real growth story. Gross margin 90.68% and debt/equity of 0 are excellent; ROE 11.38% and profitMargin 9.56% show it's actually profitable — rare for a $76M-cap. FundScore 5.75 is one of the higher scores in the group. Catalyst check is clean: Russell 2000/3000 inclusion effective late June and a recent CEO media appearance on AI fraud — both mild positives, no dilution filings, no guidance cuts, no short-seller reports. Compare to MBRX (-25% on failed trial data), IPWR ($75M shelf), TOYO (~$50M offering), PRSO ($25M Roth agreement), NXTC (all-stock merger with $320M PIPE) — all of which have material overhangs. The one real caveat on IDN is near_term_bullish of 0.2 (last few bars soft), but that's exactly what an oversold entry looks like. Waiting risks paying up after the forecast rerates.

- Near-term bullish score is only 0.2 and 1wk recent_21bar_pct is -24% — the tape is still weak and the bounce may need another shakeout to $3.30-3.40 first
- Micro-cap ($76M) with 6.3% short float — thin liquidity can cause slippage and gap risk
- PE 34.56 / fwdPe 22.06 is not cheap; if the growth story (epsNextY 25.9%) disappoints on next earnings the multiple compresses fast
- 1wk fc_long is only +2.79% — model does not see a full retrace of the -56.5% drawdown; this is a bounce trade, not a multi-quarter hold
- All small-cap AI/ID-verification names have headline sensitivity — a competitor announcement or a soft quarter can undo the setup
| # | Symbol | Verdict | Score | Read |
|---|---|---|---|---|
| 1 | IDN | BUY NOW | 8.4 | All 4 TFs positive, 0% of range, RSI 29.68, bullish_prob 1 — cleanest oversold-with-confirmation setup. |
| 2 | MORN | BUY PULLBACK | 8.0 | Best fundamentals (fundScore 8, PEG 0.74, ROE 30.7%) and 1wk fc +44%, but at 100% of range on 4h/1d — wait for a dip to $168-172. |
| 3 | AMR | BUY NOW | 7.4 | RSI 32, -21.9% recent, position 12%, all TFs positive with 1d fc_long +29.7% and bullish_prob 1. |
| 4 | HURN | BUY PULLBACK | 6.8 | Strong fundamentals (fundScore 7, recom 1.0, targetUpside 55%) but at 100% of 4h/1d range and weekly fc is negative -18/-15/-15%. |
| 5 | EVGN | BUY PULLBACK | 6.4 | 1d fc +63/+89/+83 and near_term_bullish 1.0, positive AI drug-discovery catalyst, but 1d position 100% — wait for pullback. |
| 6 | TASK | BUY PULLBACK | 6.2 | PE 5.26 / fwdPe 3.88 is cheap and 1d fc +36/+42/+39, but position 92% on 1d and 1h fc is -12%. |
| 7 | AZO | WAIT | 5.9 | Quality large-cap with fc_mid +20% on 1d, but 1wk fc -6/-11% and $50B cap makes this a low-conviction pick in a low-float lens. |
| 8 | BCDA | BUY PULLBACK | 5.6 | Position 0% and fc_long +66% on 1d, near_term_bullish 1.0, but micro-cap $12.7M biotech with ROE -950%. |
| 9 | QNTM | WAIT | 5.4 | 1d fc +35/+83/+77 with near_term_bullish 1.0, but 1wk fc_short is -33.6% and weekly forecasts are unstable. |
| 10 | BCG | WAIT | 5.2 | Profitable financial micro-cap with 1d fc +12/+32/+35 and near_term_bullish 1.0, but 1wk fc_short -28.6% and no analyst coverage. |
| 11 | PAPL | WAIT | 5.0 | 1d fc +19/+42/+55 with near_term_bullish 1.0, but profitMargin -161% and fwdPe 49.3. |
| 12 | GLMD | WAIT | 4.8 | Positive cardiac-Aramchol catalyst and 1d fc +30/+113/+137, but 1wk fc of +1392% signals model outlier — unreliable magnitudes. |
| 13 | NXTC | AVOID | 4.6 | Just announced all-stock merger + $320M PIPE — thesis is now event-driven arb, not a clean forecast trade. |
| 14 | LTRN | WAIT | 4.5 | 1d position 0% with fc +8/+25/+22 and positive AI platform catalyst, but epsNextY -33.8% and ROE -157%. |
| 15 | DRMA | WAIT | 4.3 | 1d fc +22/+100/+167 but 1wk fc of +15193% is broken model output; $5M micro-cap. |
| 16 | XTLB | WAIT | 4.2 | 1d/1wk fc strong (+23/+43/+47 and +49/+73/+108) but 1h and 4h forecasts are negative. |
| 17 | SEGG | WAIT | 4.0 | Position 0% and 1d fc +46/+68/+72 with near_term_bullish 1.0, but Nasdaq reporting deficiency and profitMargin -3609%. |
| 18 | MBRX | AVOID | 3.7 | Stock dropped 25% on 6/30 as interim MIRACLE data missed significance — headline undercuts the forecast. |
| 19 | DARE | WAIT | 3.6 | 1wk fc +25/+52/+87 but 1d fc only +0.5/+10/+8, debtEq 9.84 and operMargin -1034%. |
| 20 | RGNT | WAIT | 3.5 | Positive EU regulatory approval catalyst and 1d fc +16/+52/+45, but bullish_prob is null and 1d position 0% with -54% recent. |
| 21 | PRSO | AVOID | 3.2 | Just signed a $25M ATM with Roth on 6/30 — dilution overhang directly undercuts the +290% 1wk fc_short. |
| 22 | IPWR | AVOID | 3.0 | Filed $75M mixed-shelf prospectus 7/10 — dilution risk swamps the forecast; profitMargin -44,730% is a red flag. |
| 23 | TOYO | AVOID | 2.8 | Great fundamentals (fundScore 8, PEG 0.03) but just did ~$50M raise 6/24 and expected_return_pct in the screen is -15.6%. |
| 24 | CRE | AVOID | 2.7 | bullish_prob null, 1h fc is negative across all horizons, no analyst coverage, no target upside data. |
| 25 | USBC | AVOID | 2.5 | 1d fc is -22/-38/-11 (negative) and 1wk fc of +2231% is unreliable outlier; near_term_bullish 0.2. |
| 26 | WW | AVOID | 2.4 | Only 1d data available, debtEq 1.76, salesYoY -9.6%, bullish_prob is null. |
| 27 | SSM | AVOID | 2.2 | Only 1d timeframe available, operMargin -5643%, bullish_prob null — no multi-TF confirmation possible. |
| 28 | VEEE | AVOID | 2.0 | 1d recent_21bar +656.74% with position 100% of range — pure chase after a merger-driven parabolic move. |
| 29 | AIM | AVOID | 1.5 | bullish_prob 0.4, near_term_bullish 0, profitMargin -14,123%, and 1d fc_short is negative -28%. |
Get AI top picks & forecasts on any stock
K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.
Create your free account →Already a member? Sign in · Join our Discord